Experiments and Theoretical Considerations on Synchronisation of L 1210 Ascites Tumour Cells and Crypt Epithelia of the Mouse with Vincristine
The chemotherapy of malignant tumours is limited as many drugs are most effective against cells in one specific phase of the cell cycle. If by synchronisation the number of cells in the drug sensitive phase could be increased the chances of successful therapy would be improved. Such a cycle phase specific therapy after synchronisation is often practiced clinically using Vincristine in combination with cyclophosphamide. With this form of therapy the most important question is if it is possible to achieve in vivo synchronisation of cells.
KeywordsLeukemia Cyclophosphamide Vincristine
Unable to display preview. Download preview PDF.
- 2.Frei, E. III, Whang, J., Scoggins, R.B., Van Scott, E.J.Google Scholar
- Rail, D.P., Ben, M.: Cancer Res. 24: 1918–1925 (1964)Google Scholar
- 3.Hartenstein, R., Ehrhart, H., Hoffman, K.: Z.Kirebsforsch. 79: 213–220 (1973)Google Scholar
- 4.Jellinghaus, W., Maidhof, R., Schultze, B., Maurer, W.: Z.Krebsforsch. in press (1975)Google Scholar
- 6.Klener, P., Donner, L., Houskova, J.: Proc. 7th int. Congr. Chemother. 2: 353–355 (1972)Google Scholar
- 8.Pouillart, P., Hoang Thy Huong, T., Lheritier, J.: Bull, du Cancer 61: 509–526 (1974)Google Scholar